Money Raised in March 2024

In March there was over $9 billion raised by companies in the Biotech and Biopharma Space. I have put together a summary of the money raised below 👇🏻

Key findings:

💰The largest amount of money raided was by Moderna in Post-IPO Equity and equalled $750 million

💰The largest amount raised by a private company was by Mirador Therapeutics for $400 million in their Series A

💰$2.7 billion was raised between Grant and Series E stage funding rounds, $382 million is from unknown funding rounds and $6.98 billion came from Convertible Notes, Corporate Rounds and IPO rounds

💰Like last month the US highest number of companies raising money (135) followed by China (17) and then the United Kingdom (12)

Grant:

14,852  Atorvia Health Technologies (CA) are a pre-clinical stage biotech developing novel therapeutics for organ failure, initially focused on building a kidney franchise.

250,000 NeuroAge Therapeutics (CA, USA) is a longevity biotech firm that develops new medications to regenerate biological brain aging.

275,000 MelliCell (MA, USA) develops therapeutics for diabetes and obesity using proprietary technologies that model weight gain in human fat cells in vitro.

473,729 NEOGAP Therapeutics (SE) is a Pharmaceutical manufacturing industry.

500,000 YourChoice Therapeutics (CA, USA) is revolutionizing contraceptives for men and women by developing novel non-hormonal contraceptive products.

522,000 PsychoGenics (NJ, USA) is a research company offering preclinical testing and research services.

600,000 AivoCode (CA, USA) is an emerging biotech focused on critical and highly prevalent diseases affecting the central nervous system

1,000,000 Theromics (MA, USA) is a medical device company advancing novel technologies for interventional radiology and drug delivery.

1,093,953 ABIONYX Pharma (FR) is a biotech company discovering and developing innovative therapies for patients without existing or effective treatment.

1,500,000 Phase Genomics (WA, USA) applies Hi-C and other proximity-ligation methods to enable chromosome-scale genome assembly, metagenomic deconvolution, as well as analysis of structural genomic variation and genome architecture.

1,639,215 Orgenesis (NY, USA) focuses on a novel therapeutic treatment for diabetes by correcting malfunctioning organs with new functional tissues.

1,729,931 Confo Therapeutics (BE) is a drug discovery company building internal drug discovery programs on GPCRs addressing unmet medical need.

1,831,114 Terapet (CH) is Improving Proton Therapy for Cancer Treatment.

2,050,000 Lamassu Pharma (NC, USA) is a biotech startup that solves the critical unmet medical need for severe acute pancreatitis.

2,400,000 Citius Pharmaceuticals (NJ, USA) is a biopharmaceutical company that develops and commercializes therapeutic products.

2,600,000 NeuroRestore (CH) is a research and innovation institution that develops and implements medical remedies to restore neurological functions.

2,730,000 Scope Biosciences (NL) uses CRISPR-Cas technology to to detect nucleic acid sequences, dramatically enhancing the ability to detect genetic material with ease, speed and accuracy, for use in molecular diagnostics in infectious diseases, genotyping, and other applications.

4,100,000 Cyprium Therapeutics (NY, USA) focuses on the development of novel therapies treatment for Menkes disease and related copper metabolism disorders.

12,700,000 Access to Advanced Health Institute (WA, USA) is a nonprofit biotech research institute.

14,000,000 Forest Neurotech (CA, USA) to empower individuals and improving lives by developing a minimally invasive ultrasonic whole-brain computer interface.

14,000,000 Gilgamesh Pharmaceuticals (NY, USA) provides medicines for psychedelic, novel psychotropic drugs, depression, anxiety, and stress-related disorders.

Unknown Simulations Plus (CA, USA) is a developer of Absorption, Distribution, Metabolism, Excretion and Toxicity (ADMET).

Unknown Biosplice Therapeutics (CA, USA) is in the medical research and development for tissue-level regeneration.

Unknown NAPIGEN (DE, USA) is a biotechnology company that addresses novel genome engineering of various organisms such as plants, microbes, and animals.

Unknown Fluent Biosciences (MA, USA) is a life science company, offering a molecular analysis of cells without the use of complex microfluidic instrumentation.

Unknown Noze (CA) enables early disease detection through an AI-powered sense of smell.

Pre-Seed

500,000 Granza Bio (CA, USA) is a company that developing cancer therapies based on human body's immune system.

500,000 eDNA Explorer (CA, USA) is a SaaS Bioinformatics and Analytics Site

500,000 Eris Biotech (UT, USA) is a biotech company that developing hypoxia-activated prodrugs (HAPs) for the treatment of solid tumors.

500,000 Junction Bioscience (CA, USA) is a pharmaceutical firm that is developing an autonomous AI scientist to guide the discovery of breakthrough drugs.

800,000 TissueLab (CH) has a platform for creating organs and tissues in the lab. They offer biomaterials, equipment, and services to support tissue engineering and regenerative medicine.

810,104 Myomar Molecular (CA) is developing a diagnostic tool to identify early stages of muscle atrophy.

1,628,116 Noa Therapeutics (CA) is a preclinical biotech firm that is leading the way in the development of multimodal treatments.

2,000,000 Century Health (USA) accelerates drug development and commercialization by applying AI to real-world clinical data.

5,000,000 Portal (MA, USA) is a cell engineering platform firm that enables next generation cell engineering and cell analytics in research and clinical settings

15,000 100XBIO (MA, USA) is a biotechnology company that focuses on advancing T-cell therapy by developing technologies for testing T-cell responses.

Unknown Piramidal (CA, USA) offers AI software that transforms brain activity into easy-to-understand health data to help diagnose diseases.

Unknown Jump Therapeutics (MO, USA) is preclinical biopharmaceutical company developing precision oncology therapeutics based on research from the Department of Genetics at Washington University School of Medicine.

Seed

110,000 PERSOWN (FL, USA) provides a family health diagnostic solution delivered within a smartphone app.

150,000 Ostentus Therapeutics (CA, USA) is a biotechnology company that studies novel natural compounds in the treatment of cancer.

154,050 ImmVue Therapeutics Inc. (CA) is an early stage biotechnology company focused on immuno-oncology. They are developing small-molecule therapies that can mobilize tumor reactive T-cells to treat cancer patients. ImmVue’s approach uses a unique mechanism of action that represents a new modality in immuno-oncology to treat patients with solid tumor cancers.

636,599 CryoLogyx (UK) is an early-stage biotechnology business that develops frozen, ready-to-use cells for drug discovery.

636,599 InvenireX (UK) is a biotechnology company that offers molecular diagnostics services.

1,100,000 Van Heron Labs (AL, USA) uses genetic analysis to determine the specific nutrients that biosystems need for optimal functions.

1,100,000 PhiTech Bioinformatics (TR) provides AI-powered multi-omics based diagnostic decision support for precision medicine

1,117,795 Precision Epigenomics (AZ, USA) is a molecular diagnostic company that develops molecular diagnostic assays for cancer diagnosis.

1,576,020 Tenomix's (CA) mission is to develop novel technologies that target inefficiencies in the pathology workflow and optimize cancer care.

1,200,000 Flomics (ES) is developing novel blood-based diagnostic tools for a broad range of complex diseases. Their proprietary technology accurately identifies pattern changes in the circulating long RNA molecules of patients. With deep learning algorithms we identify RNA changes associated with disease states in a faster, cheaper and non-invasive way.

2,250,000 Helexva (PA, USA) operates as a biotech company that specializes in treatment for fatal neurodegenerative diseases.

3,183,283 Alithea Genomics (CH) backgrounds in bioengineering, molecular biology, genomics and lab operations reflect their complementary expertise.

3,600,000 Andson Biotech (GA, USA) offers Process Analytical Technologies built, from the ground up, process analytical technologies (PATs) to fill the void of existing sensor technologies for advanced biomanufacturing.

3,914,994 Kanvas Biosciences (NJ, USA) have a full-stack technology platform brings microbiome drug discovery into focus. Their spatial mapping discovery engine provides stunning pictures of the interactions and connections between host and the microbiome; an area of this vital system that we’ve never been able to completely understand before.

4,023,155 RebrAIn (FR) provides a targeted technology for planning neurosurgical procedures.

6,500,000 EfA Technologies (IL), digital diagnostic programable lab-on-hand system.

16,302,593 Cure51 (FR) mission is to create a database of cancer survivors to leverage their exceptional biological features and find new drugs to cure Cancer.

35,000,000 Relation Therapeutics (UK) is a biotechnology company that focuses on humanizing drug discovery and development.

Unknown Bailian Biotech (CN) is a new CGT drug CDO/CMO service provider that offers comprehensive CGT CDO services of novel biological pharmaceuticals.

Unknown RealSeq Biosciences (CA, USA) core expertise includes innovative proprietary technologies for bias-free small RNA/miRNA NGS library construction.

Unknown Keze Yongxin (CN) is a premium supplier of small nucleic acid raw material products. It is a high-tech company that specializes in technical research and development, as well as the production of raw and auxiliary RNA materials.

Unknown Errui Xinyueis (CN) a developer of early diagnosis technology and products for neurodegenerative diseases. It focuses on the research and use of exosome-related technologies and is committed to progressing the advancement of life and health through technological innovation.

Unknown Tushen Zhihe (CN) is an artificial intelligence protein design service provider.

Unknown Xingmu (CN) creates cutting-edge gene editing technologies and gene therapy solutions for ocular illnesses.

Unknown Astek Diagnostics (MD, USA) develops a platform that guides physicians in prescribing appropriate antibiotics for patients.

Series A

8,500,000 Tiny Health (CA, USA) is a home gut health test for mothers and babies aged 0 to 3 years.

Unknown Luohua Biotechnology (CN) offers comprehensive services for the whole organ chip and organoid industry chain.

Unknown Kerun Biology (CN) is focusing on the research and development of recombinant protein drugs.

11,400,000 Tierra Biosciences (CA, USA) is a synthetic biology company that offers an AI-driven platform with a vast range of custom proteins for research.

12,000,000 Tempo Therapeutics (CA, USA) develops materials that are immune stealth, minimally invasive, and precision-engineered for regenerative medicine.

13,836,042 Hegeia Biotechnology (CN) is a company that focused on the research and development of siRNA, tiny nucleic acid attached delivery medicines.

18,000,000 Proviva Therapeutics (CN) is a pro-drug design platform for cytokines and other fusion proteins.

20,000,000 Edgewood Oncology (MA, USA) is promoting a first-in-class therapy for malignancies that are challenging to treat.

21,000,000 Volumina (CH) is active in field of tissue engineering and develops injectable 3D scaffolds for the reconstruction of volumes of soft tissues.

27,843,519 Simnova Biotherapeutics (MA, USA) develops cell therapies for cancer treatment, with a focus on CAR-based cell therapy.

32,818,591 Asgard Therapeutics SE) is Swedish biotech company exploring reprogramming as the next leap forward in cancer immunotherapy

35,000,000 Profluent Bio (CA, USA) is an AI-first protein design company that designs novel, optimal proteins that bypass existing barriers in industry.

50,000,000 Aeovian Pharmaceuticals (CA, USA) aims to discover, develop, and commercialize therapeutics for the treatment of rare and age-related diseases.

111,000,000 Zephyr AI (VA, USA) is a healthcare technology company that reshapes traditional approaches to drug discovery and precision medicine.

150,000,000 Clasp Therapeutics (MA, USA) offers to reach of immuno-oncology with novel precision medicines that enable the immune system.

150,000,000 Avenzo Therapeutics (CA, USA) specializes in the development of oncology therapies for cancer treatment.

400,000,000 Mirador Therapeutics (CA, USA) envisions precision medicine for immune-mediated inflammatory and fibrotic diseases.

Unknown Newdel Biotech (CN) offers drug screening services along with biomedical technology development and consulting.

Unknown Oncostellae (ES) focuses on the discovery of new pharmaceutically active compounds and their development, from its initial phase

Series B

10,608,521 Pandorum Technologies Pvt. Ltd. (IN) is a Bangalore based biotechnology company with focus on tissue engineering and regenerative medicine.

13,835,085 Layerwave Bio/ChallenBio (CN) is a developer of IVD diagnostic instrument reagents and biomedical scientific research instruments.

13,889,081 Sino-Biocan (CN) focuses on the research and development of domestic tools in the field of cell and gene therapy.

22,400,000 X-Therma (CA, USA) is a biotechnology firm that develops a convergent biopreservation platform to advance regenerative medicine.

27,843,519 Hengyu Biotechnology (CN) is a CXO platform founded by a scientific research team that provides biosafety testing and related process validation.

32,554,096 Protembis (DE) is a medical device start-up company with its R&D base in the engineering and technology.

62,000,000 Nocion Therapeutics (MA, USA) is a developer of novel pharmaceuticals intended to treat the conditions arising from neurogenic inflammation.

140,025,992 Tubulis (DE) is a chemotherapeutic medication developer specializing in cancer and chronic disease treatment.

157,000,000 Engrail Therapeutics (CA, USA) is a developer of medicines to transform the lives of patients with life-limiting diseases of the nervous system.

175,000,000 Capstan Therapeutics (CA, USA) is advancing cell engineering to develop therapeutics for a broad range of diseases.

Unknown Yuce Biotechnology (CN) is a high-tech company focused on the industrialization of single-molecule immunodiagnostic technologies.

Series C

7,603,472 Nouscom (CH) is a biotech company working to develop a series of immunotherapeutics capable of selectively killing tumor cells.

9,000,000 Proscia (PA, USA) develops a pathology platform to assist routine pathology operations, enhance cancer diagnosis, and improve patient outcomes.

12,000,000 Siolta Therapeutics (CA, USA) is a biotech company focused on developing therapeutic microbial consortia to prevent and treat inflammatory diseases.

13,836,042 Zhiyi Pharmaceutics (CN) focuses on the research and development of second-generation probiotics and Live Biotherapeutics.

41,727,519 Chengdu New Radiomedicine Technology (CN) is a Chinese medical isotopes provider.

182,000,000 Sionna Therapeutics (MA, USA) is developing novel small molecule therapies to treat cystic fibrosis (CF).

259,000,000 Alumis (CA, USA) is a precision medicine company focused on the discovery, development and treatment of autoimmune disorders.

Series D

42,000,000 Phagenesis (UK) is engaged in the development of a device to treat dysphagia, a condition that disables the safe swallowing of food.

Series E

119,000,000 Rakuten Medical (CA, USA) is a biotechnology company that develops precision, cell-targeting investigational therapies.

145,000,000 FogPharma (MA, USA) is a biopharmaceutical firm that develops precision medicines for the vast majority of therapeutic targets.

Unknown

100,000 Aloe Therapeutics (LA, USA) is aimed at delivering cancer cures.

500,000 DepYmed (NY, USA) is a disease therapeutic development company that develops potent inhibitors of the enzyme PTP1B.

718,331 EnClear Therapies (MA, USA) is a biotechnology company developing device-based therapies for the treatment of neurodegenerative disease

1,125,000 Glycos Biotechnologies (TX, USA) is an International biochemical company commercializing sustainable chemicals made from renewable feedstocks.

1,634,923 Braingaze (ES) develops mind tracking solutions that solve major challenges around cognitive disorders like ADHD and Mild Cognitive Impairment

1,749,181 InGeneron (TX, USA) enables novel, safe, and evidence-based therapies that unlock the healing potential of each patient's own regenerative cells.

1,893,339 Gelmedix (MA, USA) is a developer of a biomaterial platform to improve drug delivery for complicated ophthalmic treatment.

2,007,000 CND Life Sciences (AZ, USA) develops an evidence-based tool to help confirm a diagnosis of synucleinopathy.

3,281,317 Quantistry (DE) offers the next level of chemical simulations, powered by quantum chemistry and machine learning.

4,500,000 Eisbach Bio (DE) is a biotechnology company that creates new drugs that target molecular vulnerabilities in cancer genomes.

4,708,942 Senisca (UK) is a biotech spinout company that creates a new generation of oligonucleotide-based interventions.

4,768,303 Artcline (DE) is a biotechnology company that develops diagnostic and therapeutic procedures for intensive care medicine.

5,887,549 MCAL Therapeutics (CA, USA) is a biotechnology company that develops treatment for ophthalmic diseases.

5,000,000 Emerging Therapy Solutions (MN, USA) is an insurance company that specializes in full management of gene and cell therapy for payers.

6,590,554 Holobiome (MA, USA) is an owner and operator of a therapeutic company intended to treat diseases of the enteric and central nervous systems.

6,779,976 BUGWORKS (IN) is a drug discovery company that aims to discover novel pharmaceutical assets for combating Antimicrobial Resistance (AMR).

6,907,543 RoosterBio (MD, USA) is a biotechnology company, offers synthetic biology and regenerative medicine.

7,648,868 Ability Pharmaceuticals (ES) develops human therapeutics targeting cell membranes to treat cancer and other indications with unmet medical needs.

8,667,846 Cellcolabs (SE) is a biotechnology company that production of mesenchymal stromal cells for research and clinical applications.

10,000,000 Auxilius (NY, USA) provides clinical trial financial management software for Biopharma.

10,891,347 Wobble Genomics (UK) specializes in maximizing RNA and DNA sequencing efficiency for the discovery and detection of nucleic acid biomarkers.

13,836,042 Elixiron Immunotherapeutics (TW) is a company developing therapeutics for cancer, rare, and inflammatory disorders

15,000,000 BrainCheck (TX, USA) is a mobile interactive test for cognitive health, allowing users to track their brain health to share results with clinicians.

17,249,891 Alzheon (MA, USA) is a clinical-stage biotechnology company focused on brain health, memory and aging, developing a pipeline of innovative.

29,035,704 Deep Origin (CA, USA) helps scientists solve disease, develop drugs, and extend health span by building tools that simplify R&D, simulate biology, and untangle the complexity of life. Streamline computational analysis today. Discover drugs tomorrow.

32,223,868 MISSION Therapeutics (UK) offers a platform for the development of small molecule drugs that selectively target deubiquitylating enzymes (DUBs).

40,267,575 IntraBio (UK) is a biopharmaceutical company with a late-stage drug pipeline that includes novel treatments for genetic and neurodegenerative diseases.

42,000,000 Q32 Bio (MA, USA) is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.

45,000,000 Argonaut (CA, USA) provides contract manufacturing for biopharmaceutical, diagnostics and life science organizations.

52,788,775 MITRO Biotech (CN) is the molecular imaging and pharmaceutical R&D outsourcing services.

Unknown Gaba Therapeutics (CA, USA) is a therapeutic company that develops anxiety medications.

Unknown Eigen Therapeutics (CA, USA) is a biotechnology company developing combination therapeutics for cancer

Unknown BrickBio (MA, USA) is a developer of a bioconjugation platform intended for research of site-specific modification of proteins.

Convertible Note:

15,000,000 C2N Diagnostics, LLC (MO, USA) is a privately held protein diagnostic and therapeutic discovery company.

Unknown IMIDomics (ES) is a unique company tackling Immune-Mediated Inflammatory Diseases (IMIDs).

Unknown ProEn Therapeutics (KR) is a bio drug development company that focuses on protein engineering.

Convertible Note

1,423,643 Fuse Vectors (DK) is disrupting the manufacturing process in order to provide universal access to gene therapy.

4,450,000 Aegis Life (CA, USA) works to protect human health from infectious diseases through fusogenix (their nucleic acid delivery technology) technology.

Unknown Biomeme (PA, USA) is a real-time PCR thermocycler that attaches to iPhone 5s and enables DNA diagnostics and real-time disease surveillance.

Post-IPO Equity

75,000 Cell MedX (NV, USA) is an early development stage company that focuses on the discovery, development, and commercialization of therapeutic products.

100,000 VolitionRx (SG) develops easy to use blood-based cancer tests to accurately diagnose a range of cancers.

166,195 Devonian (CA) late-stage botanical pharmaceutical corporation with novel therapeutic approaches targeting worldwide unmet medical needs.

195,000 Calidi Biotherapeutics (CA, USA) is a clinical-stage biotechnology company developing immunotherapies for cancer.

1,000,000 BioVaxys  (NY, USA) is a clinical stage biotechnology company  developing immunotherapeutic cancer vaccines targeting melanoma.

1,200,000 TFF Pharmaceuticals (TX, USA) is a clinical-stage biopharmaceutical company that develops drug products.

1,260,000 TC BioPharm (UK) develops safer, cheaper, consistent, and durable CAR-T drugs for hematological and solid tumors.

1,462,887 InnoCan Pharma (IL) is a pharma tech company.that develops novel therapeutics platforms and products to improve quality of life.

1,500,000 Scorpius Biomanufacturing (TX, USA) is a CDMO specializing in mammalian, microbial, and cell therapies for biologics development and manufacturing.

1,500,000 Vaccinex  (NY, USA) is a biotechnology company engaged in the development of novel therapeutic antibodies for neurodegenerative disorders and oncology.

1,706,540 Optibiotix Health (NY, US) discovers and develops microbial strains, compounds and formulations, which modulate the human microbiome.

1,750,000 NLS Pharma (CH) is a clinical-stage drug development company focusing on neurobehavioral and

neurocognitive disorders and their pharmacognosia.

2,500,000 BioAffinity Technologies (TX, USA) is a cancer diagnostics company that develops non-invasive, early-stage diagnostics to detect cancer and diseases.

2,900,000 MAIA Biotechnology (IL, USA) is an immuno-oncology company that focuses on developing first-in-class drugs with novel mechanisms.

3,000,000 OpGen (MD, USA) is a precision medicine company utilizing molecular diagnostics and bioinformatics to help combat infectious disease.

3,530,500 Adial Pharmaceuticals (VA, USA) develops prescription medications for addiction and related disorders.

4,000,000 First Wave BioPharma (NY, USA) is a biopharmaceutical company specializing in the development of therapies for gastrointestinal diseases.

4,400,000 Tonix Pharmaceuticals (NY, USA) develops pharmaceutical products for central nervous system disorders.

5,000,000 ASLAN Pharmaceuticals (SG) is an oncology-focused biotechnology company developing a portfolio of immuno-oncology agents and targeted therapies.

6,500,000 Quoin Pharmaceuticals (VA, USA) is into developing products which address major unmet medical needs.

6,500,000 Genprex (TX, USA) is a clinical-stage biopharmaceutical company developing revolutionary immunogene therapies for cancer.

7,000,000 Delcath Systems (NY, US) is an interventional oncology company that focuses on the treatment of metastatic liver cancer.

8,698,592 Acticor Biotech (FR) is a biopharmaceutical company developing an innovative drug for the treatment in the acute phase of ischemic stroke.

9,500,000 Molecular Templates (TX, USA) is a clinical-stage biopharmaceutical company developing therapeutic compounds for cancer and other serious diseases.

11,300,000 Xilio Therapeutics (MA, USA) is a biotechnology company that develops tumor-activated immuno-oncology therapies.

11,500,000 Cognition Therapeutics (PA, USA) develops new therapeutics to treat patients suffering from Alzheimers disease and other neurodegenerative disorders.

12,687,102 Oxford Biodynamics (UK) is a biotechnology company, which is engaged in biomarker research and development.

13,231,512 Dimerix (AU) is a clinical-stage biopharmaceutical company developing innovative new therapies in areas with unmet medical needs for global markets.

14,860,108 NervGen Pharma (CA) is a medicine company dedicated to creating solutions for the treatment of nerve damage and neurodegenerative diseases.

15,000,000 iBio (DE, USA) is an AI technology platform that develops precision antibody therapeutics

15,000,000 Danimer Scientific (GA, USA) is a biotechnology company that makes bioplastics used in disposable container coatings, packaging, and other products.

16,000,000 Aprea (SE) is a biopharmaceutical company that develops novel cancer therapeutics.

16,000,000 Beyond Air (NY, USA) is a biotechnology company that focuses on the development of drugs for the treatment of lung infections.

20,000,000 SELLAS Life Sciences (BM) is a late-stage biopharmaceutical company focused on the development of novel cancer immunotherapies for a broad range of cancer indications.

21,000,000 BioVie (MA, USA) is developing innovative therapies for the treatment of neurodegenerative conditions and advanced liver disease.

21,736,791 Onward (NL) develops an Implantable Neuro-stimulation System (INS) with real-time motion feedback and uses training tools.

24,000,000 Sangamo (CA, USA) researches, develops and commercializes engineered DNA-binding proteins for the development of novel therapeutic strategies.

25,000,000 BioXcel Therapeutics (CT, USA) is a clinical stage biopharmaceutical company focused on drug development that utilizes novel artificial intelligence.

25,136,832 Eupraxia (CA) is a clinical-stage biotech company developing locally delivered, extended-release alternatives to currently approved drugs.

26,314,404 PYC Therapeutics (AU) is a development-stage biotechnology company pioneering a new generation of RNA therapeutics

30,000,000 Nektar Therapeutics (CA, USA) develops therapeutics based on its advanced polymer conjugate chemistry technology platform.

40,000,000 Precision BioSciences (NC, USA) is a biotechnology company dedicated to improving life.

45,000,000 Erasca (CA, USA) is a developer of oncology drugs intended to provide precision oncology options.

50,000,000 Unicycive Therapeutics (CA, USA) provides development programs that focus on treating kidney diseases with unmet medical needs.

50,000,000 BIOMx (IL) is a microbiome therapeutics company developing synbio phage therapies to eradicate harmful bacteria in chronic diseases.

90,000,000 Enliven Therapeutics (CO, USA) is a precision oncology company developing small molecule therapies to extend and improve patient lives.

95,000,000 LEXEO Therapeutics  (NY, USA) utilizes gene therapy to treat genetically defined cardiovascular and central nervous system diseases.

100,000,000 Revance Therapeutics (CA, USA) develops and commercializes products and treatments for dermatological diseases.

100,000,000 Fate Therapeutics (CA, USA) is a stem cell and developmental biology research company using biological mechanisms to develop stem cell therapeutics.

100,000,000 Regulus Therapeutics (CA, USA) is a clinical stage biopharmaceutical company focused on the development and discovery of microRNA therapeutics.

100,000,000 Ventyx (CA, USA) is a biopharmaceutical company focused on advancing oral therapies for patients living with autoimmune and inflammatory disorders.

115,600,000 Avalo Therapeutics (MD, USA) is a clinical-stage biopharmaceutical company.

125,000,000 Stoke (MA, USA) is developing antisense oligonucleotide medicines that target RNA splicing to increase gene expression for treatment.

140,000,000 REGENXBIO (MD, USA) develops adeno-associated viral vector-based therapeutics and research tools, offering NAV, a recombinant AAV-vector.

150,000,000 Cybin (CA) is a biopharmaceutical company that develops psychedelic therapeutics for mental health conditions.

150,000,000 Geron (CA, USA) is a biotechnology company that specializes in developing blood cancer treatments for hematologic malignancies.

175,000,000 MindMed (NY, USA) provides psychedelic-inspired medicines and therapies for substance abuse disorders and other mental illnesses.

180,000,000 Spyre Therapeutics (CA, USA) is a biotechnology business that is developing a strong pipeline of antibody therapies.

200,000,000 Praxis (MA, USA) develops therapies for CNS disorders by leveraging genetic insights into neuronal imbalances, targeting rare to common conditions.

240,000,000 Nkarta Therapeutics (CA, USA) is a developer of cell engineering platform created to build the next generation of cell therapies.

250,000,000 Lexicon Pharmaceuticals (TX, USA) is a biopharmaceutical company that discovers and develops precise medicines for human disease.

250,000,000 BridgeBio (CA, USA) focuses on the development and commercialization of precision medicines for various genetic diseases and cancers.

366,900,000 Akero Therapeutics (MA, USA) is a biotechnology company focused on reversing the NASH epidemic by restoring the body's metabolism to a balanced state.

483,000,000 Apogee Therapeutics (CA, USA) is a biotechnology company that offers therapies for immunological and inflammatory disorders.

600,000,000 Madrigal Pharmaceuticals (PA, USA) is a biopharmaceutical company developing therapeutics for the treatment of cardiovascular-metabolic diseases.

750,000,000 Moderna Therapeutics (MA, USA) is a biotechnology company that specializes in drug discovery and drug development based on messenger RNA.

Unknown Anika Therapeutics, Inc. (MA, USA) develops, manufactures, and commercializes therapeutic products for tissue protection, healing, and repair. Its

Post-IPO Secondary

2,062,207 Intensity Therapeutics (CT, USA) is a biopharmaceutical company that provides chemotherapy treatment for cancer patients.

Post-IPO Debt

325,624 Oxurion (BE) is a biotech drug development company focused on developing therapies for retinal disorders, now focusing on diabetic eye diseases.

2,900,000 Cyclacel Pharmaceuticals (NJ, USA) develops oral therapies to treat cancers and other critical diseases.

3,473,330 Faron Pharmaceuticals (FI) is a  is a clinical stage company focused on tackling cancers via novel immunotherapies by targeting the Clever-1 receptor.

8,719,593 Ryvu (PL) is a biopharmaceutical company developing small molecule therapies that address clinical limitations of current treatments in oncology.

10,000,000 Galectin Therapeutics (GA, USA) uses galectin science and drug development to create new therapies for fibrotic diseases and cancer.

15,000,000 AEON Biopharma (CA, USA) is a biopharmaceutical company that develops novel and proprietary treatment paradigms to improve patient outcomes.

35,000,000 Armata Pharmaceuticals (CA, USA) is a biotechnology company developing novel products to diagnose, treat and prevent human and animal diseases.

48,911,403 Orexo (SE) is a pharmaceutical company developing improved treatments using proprietary drug delivery technology.

75,000,000 Bluebird Bio (CA, USA) is a biopharma company that develops and commercializes gene therapies for the treatment of severe genetic diseases and cancer.

160,000,000 Avid Bioservices' (CA, USA) expansion will double existing capacity to service both a $40m backlog and its owner Peregrine.

200,000,000 Xeris Pharmaceuticals (IL, USA) is a pharmaceutical company that develops therapies for patients in endocrinology, neurology, and gastroenterology.

300,000,000 LivaNova PLC (UK) is a global medical technology company built on nearly five decades of experience and a relentless commitment.